Cargando…
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
OBJECTIVES: Drug development trials must fulfill social value requirement but no estimates of value provided by pediatric Phase 1 trials in oncology exist. These trials involve a particularly vulnerable population. Our objective was to assess of surrogates of social value of Phase 1 trials performed...
Autores principales: | Wasylewski, Mateusz T., Strzebonska, Karolina, Koperny, Magdalena, Polak, Maciej, Kimmelman, Jonathan, Waligora, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313751/ https://www.ncbi.nlm.nih.gov/pubmed/32579564 http://dx.doi.org/10.1371/journal.pone.0234911 |
Ejemplares similares
-
Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
por: Strzebonska, Karolina, et al.
Publicado: (2022) -
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
por: Waligora, Marcin, et al.
Publicado: (2018) -
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis
por: Strzebonska, Karolina, et al.
Publicado: (2021) -
Umbrella and basket trials in oncology: ethical challenges
por: Strzebonska, Karolina, et al.
Publicado: (2019) -
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020)